Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of LifeBryan S Nelson, Camlin Tierney, Deborah Persaud, et al.
Journal of the International AIDS Society|July 19, 2022
Clinical and population-based study design considerations to accelerate the investigation of new antiretrovirals during pregnancySean S Brummel, Jeff Stringer, Ed Mills, et al.
BMC Infectious Diseases|August 11, 2016
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigenGonzague Jourdain, Nicole Ngo-Giang-Huong, Tim R Cressey, et al.
The Lancet. HIV|December 7, 2023
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept studyDeborah Persaud, Yvonne Bryson, Bryan S Nelson, et al.
AIDS (London, England)|May 30, 2024
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapyThor A Wagner, Camlin Tierney, Sharon Huang, et al.
The Lancet. HIV|September 27, 2025
ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept studyDeborah Persaud, Anne Coletti, Bryan S Nelson, et al.
The New England Journal of Medicine|March 8, 2018
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis BGonzague Jourdain, Nicole Ngo-Giang-Huong, Linda Harrison, et al.
Science Translational Medicine|May 6, 2026
VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declinesAlka Khaitan, Jane C Lindsey, Edmund V Capparelli, et al.
Pageof 7